Epigenomes最新文献

筛选
英文 中文
Markers of Biological Aging and Survival in Recurrent and Metastatic Head and Neck Cancer Patients Receiving Immunotherapy. 接受免疫治疗的复发和转移性头颈癌患者的生物衰老和生存标志物。
IF 4.1
Epigenomes Pub Date : 2026-10-19 DOI: 10.3390/epigenomes10040068
Drew R Nannini, Inamul Haque, Sushanta K Banerjee, Suman Kambhampati
{"title":"Markers of Biological Aging and Survival in Recurrent and Metastatic Head and Neck Cancer Patients Receiving Immunotherapy.","authors":"Drew R Nannini, Inamul Haque, Sushanta K Banerjee, Suman Kambhampati","doi":"10.3390/epigenomes10040068","DOIUrl":"https://doi.org/10.3390/epigenomes10040068","url":null,"abstract":"<p><strong>Background/objectives: </strong>Immunotherapy has become a cornerstone in the treatment of recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC), but reliable noninvasive biomarkers of prognosis remain limited. We investigated the associations between markers of biological aging and survival outcomes among patients with R/M HNSCC treated with immune checkpoint inhibitors (ICIs).</p><p><strong>Methods: </strong>Peripheral blood samples collected prior to ICI initiation from 100 patients with R/M HNSCC underwent DNA methylation profiling using the Illumina Infinium MethylationEPIC array. Four epigenetic age acceleration measures were estimated from DNA methylation levels and evaluated for associations with progression-free survival (PFS) and overall survival (OS).</p><p><strong>Results: </strong>Greater intrinsic and extrinsic epigenetic age acceleration were each associated with longer PFS (<i>p</i> = 0.025 and <i>p</i> = 0.048, respectively) and OS (<i>p</i> = 0.024 and <i>p</i> = 0.029, respectively). Significant interactions between GrimAge acceleration and chronological age were observed for both PFS (<i>p</i> = 0.010) and OS (<i>p</i> < 0.001). Greater GrimAge acceleration was associated with improved PFS among patients less than 65 years of age but shorter OS among patients 65 years of age or older.</p><p><strong>Conclusions: </strong>In this exploratory study, pretreatment epigenetic aging measures were associated with survival outcomes among patients with R/M HNSCC receiving ICIs. These findings suggest biological aging metrics may have clinical relevance and warrant further investigation as potential noninvasive prognostic biomarkers.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cold Stress-Induced DNA Methylation Profiling and Its Association with Terpenoid Biosynthesis in Germinating Mikania micrantha Seeds. 冷胁迫诱导的薇甘菊种子DNA甲基化分析及其与萜类生物合成的关系
IF 4.1
Epigenomes Pub Date : 2026-10-12 DOI: 10.3390/epigenomes10040067
Zijuan Yu, Can Cui
{"title":"Cold Stress-Induced DNA Methylation Profiling and Its Association with Terpenoid Biosynthesis in Germinating <i>Mikania micrantha</i> Seeds.","authors":"Zijuan Yu, Can Cui","doi":"10.3390/epigenomes10040067","DOIUrl":"https://doi.org/10.3390/epigenomes10040067","url":null,"abstract":"<p><p><i>Mikania micrantha</i>, a highly invasive weed, faces constraints on its northward range expansion in South China due to low winter temperatures. Although DNA methylation is increasingly recognized as a mediator of plant stress adaptation, it remains unknown whether epigenetic regulation couples cold-stress tolerance with the production of allelopathic secondary metabolites in invasive plants. Here, we comprehensively characterized genome-wide DNA methylation dynamics and their transcriptional consequences in germinating embryos under three temperature regimes (14 °C, 25 °C, and 30 °C) by integrating whole-genome bisulfite sequencing and RNA-Seq. Exposure to 14 °C significantly delayed germination without arresting the process. Global methylation levels were highest at CG sites (80.21-84.63%), followed by CHG (63.67-66.77%) and CHH (6.63-7.51%) contexts. Integrative analysis identified 1103 differentially methylated region-associated genes, of which 434 were also differentially expressed. Notably, KEGG enrichment of the 434 overlapping genes revealed significant overrepresentation of the sesquiterpenoid and triterpenoid biosynthesis pathways, with key mevalonate (MVA) pathway genes showing altered expression in association with DMRs at 14 °C. Because this is an integrative methylome-transcriptome association study without metabolite quantification or functional validation, these results are consistent with the hypothesis that cold-induced epigenetic reprogramming is associated with transcriptional changes in terpenoid biosynthesis, which may contribute to antioxidant and membrane-protective functions under chilling stress; the possible accumulation of allelopathic sesquiterpene lactones and any role in maintaining competitive advantage during cold seasons remain working hypotheses that require experimental validation. The results of this study offer new epigenetic perspectives and supporting data for the management and prevention of <i>M. micrantha</i> invasion.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692330/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epigenetic Landscape and Regulation of Secondary Metabolite Accumulation Implicated in Anticancer and Nutraceuticals. 抗癌和营养品中次级代谢物积累的表观遗传景观和调控。
IF 4.1
Epigenomes Pub Date : 2026-10-12 DOI: 10.3390/epigenomes10040066
Deekshitha Kosaraju, Viswanadha Naik Jarapala, Aparna Yeddala, Charumathi Polavarapu, Vasavi Singareddy, Sudhakar Reddy Palakolanu, Nese Sreenivasulu, Polavarapu Bilhan Kavi Kishor
{"title":"Epigenetic Landscape and Regulation of Secondary Metabolite Accumulation Implicated in Anticancer and Nutraceuticals.","authors":"Deekshitha Kosaraju, Viswanadha Naik Jarapala, Aparna Yeddala, Charumathi Polavarapu, Vasavi Singareddy, Sudhakar Reddy Palakolanu, Nese Sreenivasulu, Polavarapu Bilhan Kavi Kishor","doi":"10.3390/epigenomes10040066","DOIUrl":"https://doi.org/10.3390/epigenomes10040066","url":null,"abstract":"<p><p>Plants are important sources for obtaining diverse secondary metabolites which have pharmaceutical importance. Out of multiple factors that modulate their accumulation in vitro and in vivo, epigenetic factors play critical roles, adding an extra layer of regulation. This review focuses on (a) dynamic changes that occur in DNA methylation, histone acetylation, and the role of small RNAs in transcriptional and post-transcriptional modulation that alter secondary metabolism in plants under abiotic stress and (b) the role of epigenetics in secondary metabolite accumulation in the plant cell cultures. Such epigenetic factors are manipulated by applying inhibitors of DNA methylation like 5-azacytidine or histone deacetylation such as trichostatin A in intact plants as well as in cultured plant cells and hairy roots for enhanced production. This article synthesizes current findings on epigenetic engineering for improved synthesis of anticancer compounds and nutraceuticals and lists out limitations and challenges that the pharmaceutical industry is facing for their large scale production and commercialization. Main conclusion: Through epigenetic changes such as DNA methylation, histone acetylation, and non-coding RNAs, plants dynamically fine-tune specific gene expressions to adjust to environmental stresses and mediate secondary metabolite accumulation as a chemical combat mechanism.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Long Non-Coding RNAs in Breast Cancer Diagnosis and Treatment Based on Evidence from Clinical Studies: A Scoping Review. 基于临床研究证据的长链非编码rna在乳腺癌诊断和治疗中的作用:范围综述。
IF 4.1
Epigenomes Pub Date : 2026-10-07 DOI: 10.3390/epigenomes10040065
Menelaos Zafrakas, Panayiota Papasozomenou, Ioannis Gavalas, Christos Emmanouilidis, Maria Chatzidimitriou
{"title":"The Role of Long Non-Coding RNAs in Breast Cancer Diagnosis and Treatment Based on Evidence from Clinical Studies: A Scoping Review.","authors":"Menelaos Zafrakas, Panayiota Papasozomenou, Ioannis Gavalas, Christos Emmanouilidis, Maria Chatzidimitriou","doi":"10.3390/epigenomes10040065","DOIUrl":"https://doi.org/10.3390/epigenomes10040065","url":null,"abstract":"<p><p><b>Background/Objectives:</b> The aim of this scoping review was to investigate the current role and possible clinical applications of long non-coding RNAs (lncRNAs) in breast cancer diagnosis and treatment. <b>Methods:</b> A thorough search of the PubMed/MEDLINE and Scopus/EMBASE databases was carried out in accordance with the PRISMA-ScR guidelines. The inclusion criteria were as follows: Studies with lncRNA analyses of specimens from breast cancer patients and clinically relevant studies. The exclusion criteria were as follows: in silico and in vitro studies involving animal models; reviews; case series; case reports; comments; editorials; and papers not written in English. The study protocol was registered in the Open Science Framework. <b>Results:</b> After the identification of 1139 records, 312 publications were retrieved and 228 articles were selected for data extraction. Data analysis and the synthesis of evidence showed that lncRNA studies were conducted in breast tumor specimens in 212 studies and in blood samples from breast cancer patients in 20 studies. The most commonly used method was quantitative RT-PCR (in 216 studies), while many studies were complemented by in vitro (<i>n</i> = 177) and animal experiments (<i>n</i> = 75). There were 39 studies that included at least 100 specimens from breast cancer patients. <b>Conclusions:</b> At present, lncRNA analysis is not used in routine clinical practice. Clinically relevant findings coupled by results from in vitro and animal experiments suggest that various lncRNAs after appropriate validation may be used as biomarkers for breast cancer diagnosis and treatment, most notably HSAT164, CCAT2, HOTAIR, and MALAT1. To this end, larger studies involving clinical specimens from clinically relevant subgroups of breast cancer patients will be needed.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting m6A Reader Phase Separation in Synaptic Plasticity: A Hypothesis-Generating Framework for Epitranscriptomic Drug Discovery. 在突触可塑性中靶向m6A阅读器相分离:表观转录组药物发现的假设生成框架。
IF 4.1
Epigenomes Pub Date : 2026-10-05 DOI: 10.3390/epigenomes10040064
Reza Rastmanesh
{"title":"Targeting m6A Reader Phase Separation in Synaptic Plasticity: A Hypothesis-Generating Framework for Epitranscriptomic Drug Discovery.","authors":"Reza Rastmanesh","doi":"10.3390/epigenomes10040064","DOIUrl":"https://doi.org/10.3390/epigenomes10040064","url":null,"abstract":"<p><p>Epitranscriptomic drug discovery has mostly targeted the catalytic \"writers\" (METTL3/METTL14) and \"erasers\" (FTO, ALKBH5) that deposit and remove N6-methyladenosine (m6A). That strategy just hit clinical validation: STC-15, a METTL3 inhibitor, has measurable anti-tumor activity from a first-in-human oncology trial, but the same structural features that made these enzymes attractive also limit them. Inhibition shifts m6A stoichiometry globally, while an m6A mark's functional impact depends almost entirely on cellular context. YTHDF family reader proteins offer another angle. Their low-complexity domains drive liquid-liquid phase separation (LLPS). m6A binding stimulates this condensation across YTHDF paralogs-a property that matters for therapeutic selectivity. We propose a Phase Transition Threshold model in which YTHDF2's condensation concentration decides whether synaptic mRNAs are degraded or maintained in translation-competent, FMRP-associated states. Recent evidence has established YTHDF2 synaptic localization, FMRP condensate formation in neurons, and functional antagonism between the two proteins. The central unresolved question is whether condensation in living cells is nucleation-driven rather than bulk-concentration-driven. If so, concentration-centered pharmacology misses the point. We present falsifiable predictions and a staged experimental program. A more fundamental risk is that YTHDF2-mediated decay may not require condensate formation at all. If that is the case, the therapeutic premise of this Perspective collapses.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of METTL3-Mediated m6A Methylation in Hepatocellular Carcinoma Progression and Treatment. mettl3介导的m6A甲基化在肝细胞癌进展和治疗中的作用
IF 4.1
Epigenomes Pub Date : 2026-10-04 DOI: 10.3390/epigenomes10040063
Bala Gamage Nalaka Hasith Maduranga, Hee Doo Yang, Su In Lee, Jung Woo Eun, Sun-Young Lim, Hyung Seok Kim, Jee-Yeong Jeong
{"title":"The Role of METTL3-Mediated m<sup>6</sup>A Methylation in Hepatocellular Carcinoma Progression and Treatment.","authors":"Bala Gamage Nalaka Hasith Maduranga, Hee Doo Yang, Su In Lee, Jung Woo Eun, Sun-Young Lim, Hyung Seok Kim, Jee-Yeong Jeong","doi":"10.3390/epigenomes10040063","DOIUrl":"https://doi.org/10.3390/epigenomes10040063","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide. Emerging evidence has established N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) RNA methylation as a key epitranscriptomic mechanism underlying hepatocarcinogenesis. Methyltransferase-like 3 (METTL3), the catalytic core of the m<sup>6</sup>A methyltransferase complex (MTC), forms a heterodimer with METTL14 and cooperates with auxiliary components of the MTC to deposit m<sup>6</sup>A modifications that modulate mRNA stability, splicing, nuclear export, and translation. In this review, we comprehensively summarize the current understanding of METTL3 biology in HCC, focusing on its structure, assembly within the MTC, regulation of coding and non-coding RNAs, and its roles in driving key oncogenic signaling cascades, such as JAK/STAT3, PI3K/AKT/mTOR, Wnt/β-catenin, Hippo/YAP, Notch, Hedgehog, and epithelial-mesenchymal transition. In addition, we discussed how METTL3 remodels the tumor immune microenvironment (TIME) by regulating immune responses and metabolic pathways promoting immune evasion and therapy resistance. Therapeutic strategies targeting METTL3-including small-molecule inhibitors, CRISPR-Cas9 approaches, combination immunotherapy, and tumor-selective delivery systems-are discussed together with the challenges that continue to limit clinical translation. Collectively, these findings position METTL3 as a central epitranscriptomic regulator of HCC progression; however, further mechanistic and clinical validation remains necessary to establish its utility as a therapeutic target and prognostic biomarker.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic m6A Methylation in Neurodevelopmental and Neurodegenerative Disorders. 动态m6A甲基化在神经发育和神经退行性疾病中的作用。
IF 4.1
Epigenomes Pub Date : 2026-10-03 DOI: 10.3390/epigenomes10040062
Ambrose Loc Ngo, Xuemei Qu, Niki Gharavi Alkhansari, Linda Nguyen, Uyen Tam Nguyen, Huiping Zhang
{"title":"Dynamic m<sup>6</sup>A Methylation in Neurodevelopmental and Neurodegenerative Disorders.","authors":"Ambrose Loc Ngo, Xuemei Qu, Niki Gharavi Alkhansari, Linda Nguyen, Uyen Tam Nguyen, Huiping Zhang","doi":"10.3390/epigenomes10040062","DOIUrl":"https://doi.org/10.3390/epigenomes10040062","url":null,"abstract":"<p><p>N<sup>6</sup>-methyladenosine (m<sup>6</sup>A), the most prevalent internal modification in eukaryotic RNA, has emerged as a key epitranscriptomic regulator in the central nervous system, coordinating gene expression programs that govern neural development, synaptic plasticity, and neuronal adaptation throughout the lifespan. This review synthesizes emerging evidence that m<sup>6</sup>A dysregulation represents a shared epitranscriptomic mechanism linking neurodevelopmental and neurodegenerative disorders, highlighting a mechanistic convergence that bridges these traditionally distinct disease categories. Dysregulation of m<sup>6</sup>A-mediated control of neurogenesis, synaptic maturation, and dopaminergic development has been implicated in neurodevelopmental disorders, including autism spectrum disorder, attention-deficit/hyperactivity disorder, and intellectual disability. In neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, m<sup>6</sup>A dysregulation mediates multiple interconnected pathogenic processes, including neuroinflammation, mitochondrial dysfunction, tau hyperphosphorylation and aggregation, α-synuclein dysregulation, and impaired neuronal repair. Environmental stressors and metabolic perturbations modulate m<sup>6</sup>A modification patterns, suggesting that gene-environment interactions contribute to disease susceptibility through epitranscriptomic mechanisms. m<sup>6</sup>A modification functions as a dynamic molecular switch governing neural plasticity and circuit function across early development, adulthood, and aging, and its dysregulation predisposes individuals to neurological disease manifestation throughout the lifespan. Advances in cell-type-specific and circuit-resolved m<sup>6</sup>A profiling will deepen our understanding of m<sup>6</sup>A dysregulation and strengthen its translational potential as both a diagnostic biomarker and a therapeutic target in neurological diseases. Furthermore, we evaluate pharmacological and molecular strategies targeting m<sup>6</sup>A regulatory machinery, including the writers METTL3/METTL14, the erasers FTO/ALKBH5, and reader proteins, as promising therapeutic approaches to restore aberrant neuronal circuit function in neurodevelopmental and neurodegenerative disorders.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spn1 Maintains Nucleosome Organization at Transcription End Sites. Spn1维持转录末端核小体的组织。
IF 4.1
Epigenomes Pub Date : 2026-09-30 DOI: 10.3390/epigenomes10040061
Uwe Schwartz
{"title":"Spn1 Maintains Nucleosome Organization at Transcription End Sites.","authors":"Uwe Schwartz","doi":"10.3390/epigenomes10040061","DOIUrl":"https://doi.org/10.3390/epigenomes10040061","url":null,"abstract":"<p><strong>Background/objectives: </strong>Transcription by RNA polymerase II (RNAPII) occurs within chromatin and requires continuous disassembly and reassembly of nucleosomes. Histone chaperones associate with RNAPII, facilitate transcription, and maintain nucleosome organization. This study investigated the role of the conserved histone chaperone Spn1 in coordinating chromatin organization with transcription termination in <i>Saccharomyces cerevisiae</i>.</p><p><strong>Methods: </strong>Spn1 interacts with elongating RNAPII via Spt6 and its function was examined by reanalyzing published MNase-seq, RNAPII ChIP-seq, NET-seq, and TSS-seq datasets.</p><p><strong>Results: </strong>Mutations that disrupt the Spn1-Spt6 interaction at nonpermissive temperatures caused a pronounced loss of nucleosome array regularity at polyadenylation (pA) sites, whereas nucleosome organization around transcription start sites was less affected. These mutants also showed shorter nucleosome repeat lengths at gene ends. RNAPII accumulated near pA sites and displayed increased termination-proximal stalling, consistent with impaired transcription termination. In addition, transcription of neighboring downstream genes in tandem orientation was preferentially reduced, suggesting interference between termination of the upstream gene and initiation at the neighboring promoter.</p><p><strong>Conclusions: </strong>Together, these results identify Spn1 as an important determinant of chromatin organization at gene ends and suggest that it helps maintain transcriptional fidelity across closely spaced genes.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DNA Methylation and Metabolic Syndrome in Midlife Women of the ELEMENT Cohort. ELEMENT队列中年妇女的DNA甲基化和代谢综合征。
IF 4.1
Epigenomes Pub Date : 2026-09-24 DOI: 10.3390/epigenomes10040060
Jiahe Tian, Jaclyn M Goodrich, Lindsey English, Dana C Dolinoy, Erica C Jansen, Peter X K Song, Libni A Torres-Olascoaga, Martha M Téllez-Rojo, Karen E Peterson
{"title":"DNA Methylation and Metabolic Syndrome in Midlife Women of the ELEMENT Cohort.","authors":"Jiahe Tian, Jaclyn M Goodrich, Lindsey English, Dana C Dolinoy, Erica C Jansen, Peter X K Song, Libni A Torres-Olascoaga, Martha M Téllez-Rojo, Karen E Peterson","doi":"10.3390/epigenomes10040060","DOIUrl":"https://doi.org/10.3390/epigenomes10040060","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Metabolic syndrome (MetS) is a cluster of metabolic risk factors that markedly increase the risk of cardiovascular disease and type 2 diabetes. Its prevalence exceeds 50% among Mexican women. A growing number of studies suggest that DNA methylation, an epigenetic mechanism, is linked to MetS. Methylation risk scores (MRS) may be able to predict future disease risk, yet prospective studies with MRS and MetS are rare, especially in Hispanic populations. We aimed to (1) replicate previously reported locus-specific DNA methylation-MetS associations, (2) identify additional loci, and (3) evaluate an MRS for predicting MetS among a sample of midlife Mexican women. <b>Methods</b>: We analyzed 149 women from the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) cohort with DNA methylation measured in blood leukocytes collected around 2008 and MetS assessed approximately ten years later. Logistic regression was applied to a priori loci, and then all loci on the Infinium EPICv1 array. MRS performance was evaluated by cross-validation. <b>Results</b>: Four loci-probe ID cg11024682 (<i>SREBF1</i>), cg06500161 (<i>ABCG1</i>), cg22891070 (<i>HIF3A</i>), and cg02650017 (<i>PHOSPHO1</i>)-showed consistent associations with MetS. For example, each 1-percentage-point increase in methylation at cg11024682 (<i>SREBF1</i>) was associated with higher odds of MetS in the fully adjusted model (OR = 1.30; 95% CI: 1.12-1.52). No additional loci reached Bonferroni significance, though marginal associations with MetS components were observed. The MRS derived from four replicated loci was associated with higher odds of MetS per 1-SD increase in the training set (OR = 3.55; 95% CI: 2.03-6.22). In the independent testing set, the MRS-only model improved prediction compared with the baseline covariate-only model (AUC = 0.652 vs. 0.398; ΔAUC = +0.254). <b>Conclusions</b>: This study provides prospective evidence that specific DNA methylation markers are associated with MetS risk in midlife Mexican women. These loci, now replicated in several cohorts, are promising biomarkers for early identification and prevention of MetS.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 4","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
KDM4B Maintains Pyruvate Dehydrogenase Complex Expression to Support Mitochondrial Metabolism and Survival in Cancer Cells. KDM4B维持丙酮酸脱氢酶复合物表达支持线粒体代谢和癌细胞存活
IF 4.1
Epigenomes Pub Date : 2026-09-16 DOI: 10.3390/epigenomes10030059
Sachiko Sato, Arif Ul Hasan, Mami Obara, Eiichi Taira
{"title":"KDM4B Maintains Pyruvate Dehydrogenase Complex Expression to Support Mitochondrial Metabolism and Survival in Cancer Cells.","authors":"Sachiko Sato, Arif Ul Hasan, Mami Obara, Eiichi Taira","doi":"10.3390/epigenomes10030059","DOIUrl":"10.3390/epigenomes10030059","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Metabolic reprogramming is a hallmark of cancer and requires coordinated regulation of glycolysis and mitochondrial metabolism. The pyruvate dehydrogenase complex (PDC) links these pathways by catalyzing the conversion of pyruvate to acetyl-CoA, yet the epigenetic mechanisms regulating PDC expression remain poorly understood. We investigated whether the histone demethylase KDM4B regulates PDC expression and mitochondrial metabolism in cancer cells. <b>Methods:</b> Human colorectal carcinoma (HCT-116), cervical adenocarcinoma (HeLa), melanoma (G-361), and non-malignant human proximal tubule epithelial (HK-2) cells were analyzed using glucose-response assays, RNA sequencing, RT-qPCR, immunoblotting, metabolic assays, fluorescence imaging, and cell viability analyses. KDM4B was disrupted by small interfering RNA (siRNA) and the selective inhibitor NCGC00244536. <b>Results:</b> Glucose availability induced coordinated upregulation of the PDC subunits PDHA1, DLD, and DLAT and was associated with increased proliferation and KDM4B expression in cancer cells. Both genetic depletion and pharmacological inhibition of KDM4B suppressed PDC expression and increased the repressive histone mark H3K9me3. Exploratory RNA-seq analysis revealed coordinated metabolic transcriptional reprogramming characterized by induction of glycolytic genes and suppression of PDC, the tricarboxylic acid cycle, and electron transport chain genes, together with increased PDK1 and reduced PDP1 expression, consistent with impaired mitochondrial glucose oxidation. These changes were accompanied by reduced pyruvate dehydrogenase activity, extracellular pyruvate accumulation, ATP depletion, impaired glucose uptake, mitochondrial depolarization, caspase-3 activation, increased lactate dehydrogenase release, reduced viability, and diminished proliferative capacity. These effects were generally more pronounced in the cancer cell models than in HK-2 cells. <b>Conclusions:</b> Our findings identify KDM4B as a regulator associated with maintenance of PDC expression and mitochondrial glucose metabolism in cancer cells. KDM4B inhibition suppresses PDC abundance and activity and is accompanied by metabolic dysfunction, mitochondrial depolarization, and reduced cell survival. These findings support a model in which the KDM4B-PDC axis may contribute to metabolic homeostasis and survival in cancer cells and suggest that this pathway may represent a potential therapeutic vulnerability.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"10 3","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13605158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149042151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书